RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for 599-79-1:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- USES: Sulfasalazine is used for treatment of ulcerative colitis, rheumatoid arthritis, and polyarticular-course juvenile rheumatoid arthritis.
- PHARMACOLOGY: The mode of action of sulfasalazine or its metabolites, 5-aminosalicylic acid (mesalamine) and sulfapyridine, is unknown but may be related to anti-inflammatory and immunomodulatory properties of the agent.
- EPIDEMIOLOGY: Overdose is rare.
- WITH THERAPEUTIC USE
- COMMON: Anorexia, headache, nausea, vomiting, abdominal discomfort, dyspepsia, and rash. Other rare adverse effects include pruritus, urticaria, rash, fever, cyanosis, dizziness, malaise, depression, fatigue, insomnia, confusion, stomatitis, elevated liver enzyme levels, hepatic necrosis, granulomatous hepatitis, folic acid deficiency, Heinz body anemia, hemolytic anemia, leukopenia, thrombocytopenia, neutropenia, macrocytosis, megaloblastic anemia, agranulocytosis, methemoglobinemia, aplastic anemia, tachycardia, acute allergic reaction, fixed drug eruption, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, pancreatitis, taste disturbances, renal calculi, nephrotic syndrome, myopathy, pneumonia, and pulmonary infiltrates.
- WITH POISONING/EXPOSURE
- TOXICITY: Overdose effects are anticipated to be an extension of adverse effects observed following therapeutic doses. Nausea, vomiting, abdominal pain and central nervous system symptoms (eg, drowsiness, seizures, headache), methemoglobinemia, and tachycardia have been reported following sulfasalazine overdose.
© 2011-2020 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.